| Directors: | Dr Charmaine Gittleson (Chair) Dr Gil Price Dr James Garner |
| Auditors: | William Buck Audit (Vic) Pty Ltd Level 20, 181 William Street, Melbourne, Victoria, 3000 |
| Solicitors: | Minter Ellison Collins Arch, 447 Collins Street, Melbourne, Victoria, 3000 |
| Company Secretary: | Ms Deborah Ambrosini |
| Company: | Percheron Therapeutics Limited ACN 095 060 745 |
| Share Register: | Boardroom Pty Limited Level 12, 225 George Street, Sydney, NSW 2000 Telephone: 1300 737 760 International: +61 2 9290 9600 |
| Registered Office: | L30, Collins Place 35 Collins Street Melbourne, VIC 3000 Australia Telephone: +61 3 9827 8999 |
| Australian Stock Exchange: | Percheron Therapeutics Limited shares are quoted on the Australian Stock Exchange. ASX Code: PER |
| Principal Administrative Office & Mailing Address: | L30, Collins Place 35 Collins Street Melbourne, VIC 3000 Australia Telephone: +61 3 9827 8999 Facsimile: +61 3 9859 7701 |
| OTCQB Venture Market Information: | Percheron Therapeutics Limited (OTCQB: PERCF) trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on Ordinary Share Information: Symbol: PERCF Market: OTCQB CUSIP: Q04007128 Country: Australia Effective Date: November 29, 2024 |
| Bankers: | Commonwealth Bank of Australia, Melbourne, Victoria |
| Website: | www.percherontx.com |
